Abstract
Soy isoflavone’s (genistein and daidzein in particular) biological significance has been thoroughly studied for decades, so we started from the premise that refreshed investigation approach in this field should consider identification of their new molecular targets. In addition to recently described epigenetic aspects of polyphenole action, the cell membrane constituents-mediated effects of soy isoflavones are worthy of special attention. Accordingly, the expanding concept of membrane steroid receptors and rapid signaling from the cell surface may include the prominent role of these steroid-like compounds. It was observed that daidzein strongly interacts with membrane estrogen receptors in adrenal medullary cells. At low doses, daidzein was found to stimulate catecholamine synthesis through extracellular signal-regulated kinase 1/2 or protein kinase A pathways, but at high doses, it inhibited catecholamine synthesis and secretion induced by acetylcholine. Keeping in mind that catecholamine excess can contribute to the cardiovascular pathologies and that catecholamine lack may lead to depression, daidzein application promises to have a wide range of therapeutic effects. On the other hand, it was shown in vitro that genistein inhibits LNCaP prostate cancer cells invasiveness by decreasing the membrane fluidity along with immobilization of the androgen receptor containing membrane lipid rafts, with down regulation of the androgen receptors and Akt signaling. These data are promising in development of the molecular pharmacotherapy pertinent to balanced soy isoflavone treatment of cardiovascular, psychiatric, and steroid-related malignant diseases.
Similar content being viewed by others
References
Adlanmerini M, Solinhac R, Abot A, Fabre A, Raymond-Letron I, Guihot AL, Boudou F, Sautier L, Vessières E, Kim SH, Lière P, Fontaine C, Krust A, Chambon P, Katzenellenbogen JA, Gourdy P, Shaul PW, Henrion D, Arnal JF, Lenfant F (2014) Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions. Proc Natl Acad Sci USA 111:E283–E290
Ajdžanović V, Spasojević I, Filipović B, Šošić-Jurjević B, Sekulić M, Milošević V (2010) Effects of genistein and daidzein on erythrocyte membrane fluidity: an electron paramagnetic resonance study. Can J Physiol Pharmacol 88:497–500
Ajdžanović V, Spasojević I, Šošić-Jurjević B, Filipović B, Trifunović S, Sekulić M, Milošević V (2011) The negative effect of soy extract on erythrocyte membrane fluidity: an electron paramagnetic resonance study. J Membr Biol 239:131–135
Ajdžanović V, Milošević V, Spasojević I (2012) Glucocorticoid excess and disturbed hemodynamics in advanced age: the extent to which soy isoflavones may be beneficial. Gen Physiol Biophys 31:367–374
Ajdžanović V, Mojić M, Maksimović-Ivanić D, Bulatović M, Mijatović S, Milošević V, Spasojević I (2013) Membrane fluidity, invasiveness and dynamic phenotype of metastatic prostate cancer cells after treatment with soy isoflavones. J Membr Biol 246:307–314
Ajdžanović V, Medigović I, Pantelić J, Milošević V (2014) Soy isoflavones and cellular mechanics. J Bioenerg Biomembr 46:99–107
Asnacios A, Hamant O (2012) The mechanics behind cell polarity. Trends Cell Biol 22:584–591
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Beck V, Rohr U, Jungbauer A (2005) Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 94:499–518
Benten WP, Lieberherr M, Giese G, Wrehlke C, Stamm O, Sekeris CE, Mossmann H, Wunderlich F (1999) Functional testosterone receptors in plasma membranes of T cells. FASEB J 13:123–133
Blake C, Fabick KM, Setchell KDR, Lund TD, Lephart ED (2011) Neuromodulation by soy diets or equol: Anti-depressive & anti-obesity-like influences, age- & hormone-dependent effects. BMC Neurosci 12:28
Cinar B, Mukhopadhyay NK, Meng G, Freeman MR (2007) Phosphoinositide 3-kinase-independent non-genomic signals transit from the androgen receptor to Akt1 in membrane raft microdomains. J Biol Chem 282:29584–29593
El Touny LH, Banerjee PP (2007) Akt GSK-3 pathway as a target in genistein induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. Carcinogenesis 28:1710–1717
Esquela-Kercher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
Falkenstein E, Tillmann HC, Christ M, Feuring M, Wehling M (2000) Multiple actions of steroid hormones—a focus on rapid, nongenomic effects. Pharmacol Rev 52:513–556
Filardo E, Quinn J, Pang Y, Graeber C, Shaw S, Dong J, Thomas P (2007) Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 148:3236–3245
Foradori CD, Weiser MJ, Handa RJ (2008) Non-genomic actions of androgens. Front Neuroendocrinol 29:169–181
Gatson JW, Kaur P, Singh M (2006) Dihydrotestosterone differentially modulates the mitogen-activated protein kinase and the phosphoinositide 3-kinase/Akt pathways through the nuclear and novel membrane androgen receptor in C6 cells. Endocrinology 147:2028–2034
Giguère V, Yang N, Sequi P, Evans RM (1988) Identification of a new class of steroid hormone receptors. Nature 331:91–94
Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J (1986) Sequence and expression of human estrogen receptor complementary DNA. Science 231:1150–1154
Hammes SR, Levin ER (2011) Minireview: recent advances in extranuclear steroid receptor actions. Endocrinology 152:4489–4495
Heinlein CA, Chang C (2002) The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16:2181–2187
Heinlein CA, Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25:276–308
Jacob J, Sebastian KS, Devassy S, Priyadarsini L, Farook MF, Shameem A, Mathew D, Sreeja S, Thampan RV (2006) Membrane estrogen receptors: genomic actions and post transcriptional regulation. Mol Cell Endocrinol 246:34–41
Kalaiselvan V, Kalaivani M, Vijayakumar A, Sureshkumar K, Venkateskumar K (2010) Current knowledge and future direction of research on soy isoflavones as a therapeutic agents. Pharmacogn Rev 4:111–117
Kallergi G, Agelaki S, Markomanolaki H, Georgoulias V, Stournaras C (2007) Activation of FAK/PI3K/Rac1 signaling controls actin reorganization and inhibits cell motility in human cancer cells. Cell Physiol Biochem 20:977–986
Kampa M, Papakonstanti EA, Hatzoglou A, Stathopoulos EN, Stournaras C, Castanas E (2002) The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors, which increase PSA secretion and modify actin cytoskeleton. FASEB J 16:1429–1431
Kampa M, Nifli AP, Charalampopoulos I, Alexaki VI, Theodoropoulos PA, Stathopoulos EN, Gravanis A, Castanas E (2005) Opposing effects of estradiol- and testosterone-membrane binding sites on T47D breast cancer cell apoptosis. Exp Cell Res 307:41–51
Kampa M, Kogia C, Theodoropoulos PA, Anezinis P, Charalampopoulos I, Papakonstanti EA, Stathopoulos EN, Hatzoglou A, Stournaras C, Gravanis A, Castanas E (2006) Activation of membrane androgen receptors potentiates the antiproliferative effects of paclitaxel on human prostate cancer cells. Mol Cancer Ther 5:1342–1351
Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863–870
Kumar R, Zakharov MN, Khan SH, Miki R, Jang H, Toraldo G, Singh R, Bhasin S, Jasuja R (2011) The dynamic structure of the estrogen receptor. J Amino Acids 2011:812540
Levin ER (2011) Minireview: extranuclear steroid receptors: roles in modulation of cell functions. Mol Endocrinol 25:377–384
Liao RS, Ma S, Miao L, Li R, Yin Y, Raj GV (2013) Androgen receptor-mediated non-genomic regulation of prostate cancer cell proliferation. Transl Androl Urol 2:187–196
Liu M, Yanagihara N, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y (2007) Dual effects of daidzein, a soy isoflavone, on catecholamine synthesis and secretion in cultured bovine adrenal medullary cells. Endocrinology 148:5348–5354
Liu S, Le May C, Wong WP, Ward RD, Clegg DJ, Marcelli M, Korach KS, Mauvais-Jarvis F (2009) Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58:2292–2302
Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP (2001) Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 276:13442–13451
Lyng FM, Jones GR, Rommerts FF (2000) Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations. Biol Reprod 63:736–747
Madeo A, Maggiolini M (2010) Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res 70:6036–6046
Mahmoud AM, Yang W, Bosland MC (2014) Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol 140:116–132
Marino M, Pellegrini M, La Rosa P, Acconcia F (2012) Susceptibility of estrogen receptor rapid responses to xenoestrogens: physiological outcomes. Steroids 77:910–917
McEwen B (2002) Estrogen actions throughout the brain. Recent Prog Horm Res 57:357–384
Milenkovic D, Deval C, Gouranton E, Landrier JF, Scalbert A, Morand C, Mazur A (2012) Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLoS ONE 7:e29837
Milenkovic D, Jude B, Morand C (2013) miRNA as molecular target of polyphenols underlying their biological effects. Free Radic Biol Med 64:40–51
Miska EA (2005) How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 15:563–568
Moriarty K, Kim KH, Bender JR (2006) Minireview: estrogen receptor-mediated rapid signaling. Endocrinology 147:5557–5563
Nadal A, Rovira JM, Laribi O, Leon-quinto T, Andreu E, Ripoll C, Soria B (1998) Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor. FASEB J 12:1341–1348
Norman AW, Mizwicki MT, Norman DP (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3:27–41
Oh HY, Leem J, Yoon SJ, Yoon S, Hong SJ (2010) Lipid raft cholesterol and genistein inhibit the cell viability of prostate cancer cells via the partial contribution of EGFR-Akt/p70S6k pathway and down-regulation of androgen receptor. Biochem Biophys Res Commun 393:319–324
Papadopoulou N, Charalampopoulos I, Anagnostopoulou V, Konstantinidis G, Föller M, Gravanis A, Alevizopoulos K, Lang F, Stournaras C (2008) Membrane androgen receptor activation triggers down-regulation of PI-3K/Akt/NF-kappaB activity and induces apoptotic responses via Bad, FasL and caspase-3 in DU145 prostate cancer cells. Mol Cancer 7:88
Papakonstanti EA, Kampa M, Castanas E, Stournaras C (2003) A rapid, nongenomic, signaling pathway regulates the actin reorganization induced by activation of membrane testosterone receptors. Mol Endocrinol 17:870–881
Peterziel H, Mink S, Schonert A, Becker M, Klocker H, Cato AC (1999) Rapid signalling by androgen receptor in prostate cancer cells. Oncogene 18:6322–6329
Pralle A, Keller P, Florin EL, Simons K, Hörber JK (2000) Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 148:997–1008
Rahman F, Christian HC (2007) Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18:371–378
Roepke TA, Ronnekleiv OK, Kelly MJ (2011) Physiological consequences of membrane-initiated estrogen signaling in brain. Front Biosci (Landmark Ed) 16:1560–1573
Setchell KDR (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68:1333S–1346S
Soltysik K, Czekaj P (2013) Membrane estrogen receptors—is it an alternative way of estrogen action? J Physiol Pharmacol 64:129–142
Sud N, Wiseman DA, Black SM (2010) Caveolin 1 is required for the activation of endothelial nitric oxide synthase in response to 17beta-estradiol. Mol Endocrinol 24:1637–1649
Sun YH, Gao X, Tang YJ, Xu CL, Wang LH (2006) Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl 27:671–678
Tarahovsky YS, Kim YA, Yagolnik EA, Muzafarov EN (2014) Flavonoid-membrane interactions: involvement of flavonoid-metal complexes in raft signaling. BBA Biomembr 1838:1235–1246
Watson CS, Gametchu B (1999) Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 220:9–19
Watson CS, Alyea RA, Jeng YJ, Kochukov MY (2007) Nongenomic actions of low concentration estrogens and xenoestrogens on multiple tissues. Mol Cell Endocrinol 274:1–7
Westfall TC, Westfall DP (2005) Adrenergic agonists and antagonists. In: Brunton LL, Lazo JS, Parker KL (eds) Goodman, Gilman the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York, pp 237–295
Xie H, Sun M, Liao XB, Yuan LQ, Sheng ZF, Meng JC, Wang D, Yu ZY, Zhang LY, Zhou HD, Luo XH, Li H, Wu XP, Wei QY, Tang SY, Wang ZY, Liao EY (2011) Estrogen receptor α36 mediates a bone-sparing effect of 17β-estradiol in postmenopausal women. J Bone Miner Res 26:156–168
Yanagihara N, Liu M, Toyohira Y, Tsutsui M, Ueno S, Shinohara Y, Takahashi K, Tanaka K (2006) Stimulation of catecholamine synthesis through unique estrogen receptors in the bovine adrenomedullary plasma membrane by 17β-estradiol. Biochem Biophys Res Commun 339:548–553
Yanagihara N, Toyohira Y, Shinohara Y (2008) Insights into the pharmacological potential of estrogens and phytoestrogens on catecholamine signaling. Ann NY Acad Sci 1129:96–104
Yu J, Akishita M, Eto M, Koizumi H, Hashimoto R, Ogawa S, Tanaka K, Ouchi Y, Okabe T (2012) Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem Biophys Res Commun 424:538–543
Zicha J, Kunes J, Devynck MA (1999) Abnormalities of membrane function and lipid metabolism in hypertension. Am J Hypertens 12:315–331
Acknowledgments
This work was supported by the Ministry of Science, Education and Technological Development of the Republic of Serbia, Grant number 173009. We wish to express our gratitude to Ivan Spasojević PhD, Life Systems Department, Institute for Multidisciplinary Research, Belgrade, Serbia for the valuable assistance during manuscript preparation.
Conflict of interest
Vladimir Ajdžanović, Ivana Medigović, Jasmina Živanović, Marija Mojić and Verica Milošević declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ajdžanović, V., Medigović, I., Živanović, J. et al. Membrane Steroid Receptor-Mediated Action of Soy Isoflavones: Tip of the Iceberg. J Membrane Biol 248, 1–6 (2015). https://doi.org/10.1007/s00232-014-9745-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00232-014-9745-x